Spanish Oncology Genito-urinary Group
Clinical trials sponsored by Spanish Oncology Genito-urinary Group, explained in plain language.
-
New drug combo shows promise for tough bladder cancer cases
Disease control Recruiting nowThis study tests a drug called erdafitinib, alone or with another drug (cetrelimab), given before surgery to people with muscle-invasive bladder cancer whose tumors have certain gene changes. The goal is to see if these treatments can shrink or eliminate the cancer before the bla…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 19, 2026 11:49 UTC
-
Spanish study to see if new cancer drugs deliver in real life
Knowledge-focused Recruiting nowThis study looks at how well recently approved drugs for genitourinary cancers (like kidney, bladder, and prostate cancers) work in routine medical practice. Researchers will collect data from 500 patients across Spain who are already taking these medications. The goal is to see …
Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Knowledge-focused
Last updated May 26, 2026 12:07 UTC